FDA Releases 'Guiding Principles' For AI/ML Device Development

The principles identify areas in which international standards organizations and other collaborative groups could advance what the agency calls Good Machine Learning Practice.

The U.S. Food and Drug Administration released a list of "guiding principles" this week aimed at helping promote the safe and effective development of medical devices that use artificial intelligence and machine learning.  

The FDA, along with its U.K. and Canadian counterparts, said the principles are intended to lay the foundation for Good Machine Learning Practice.  

"As the AI/ML medical device field evolves, so too must GMLP best practice and consensus standards," said the agency regarding the principles.